Histone modification of endothelial-mesenchymal transition in cardiovascular diseases

Overview of attention for article published in Frontiers in Cardiovascular Medicine, December 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (67th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 2 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 12,540 followers.

RT @HaoYin20: Epigenetics #EndMT Histone modification of endothelial-mesenchymal transition in cardiovascular diseases JMJD2B-H3K9me3 p3…

12 Feb 2023

Reply Repost Favourite

Epigenetics #EndMT Histone modification of endothelial-mesenchymal transition in cardiovascular diseases JMJD2B-H3K9me3 p300 HDAC2/3/4/8/9 SIRT1/3/6 Histone ubiquitination Ring1A/B 🥸 Dr. Jiangfang Lian & Zhou Jianqing labs @FrontCVMedicine 2022

12 Feb 2023

Reply Repost Favourite

We've detected a paper from Frontiers in Cardiovascular Medicine that cites a retracted paper post-retraction. Citing paper: https://t.co/bYQ0y2QywE Retracted paper: https://t.co/pfux2n3bVn

28 Jan 2023

Reply Repost Favourite

New Research: Histone modification of endothelial-mesenchymal transition in cardiovascular diseases: Endothelial-mesenchymal transition (EndMT) is a differentiation process in which endothelial cells lose their own characteristics and… https://t.co/sY7EsDW

08 Dec 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.